Immunoprecise Antibodies Ltd IPA:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/05/21 EST
11.70quote price arrow down-0.26 (-2.17%)
Volume
147,455
52 week range
2.08 - 33.34

...

Loading . . .

KEY STATS

  • Open11.75
  • Day High12.14
  • Day Low10.10
  • Prev Close11.96
  • 52 Week High33.34
  • 52 Week High Date12/30/20
  • 52 Week Low2.08
  • 52 Week Low Date03/18/20
  • Market Cap194.91M
  • Shares Out16.76M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change333.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-85.34
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Immunoprecise Antibodies Ltd News

There is no recent news for this security.

Latest IPA News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Immunoprecise Antibodies Ltd, formerly Tanqueray Exploration Ltd, is a Canada-based supplier of custom hybridoma development services. The Company's geographical segments include United States of America and Canada. It offers products, such as antibodies and hybridoma licensing. It offers various services, such as ImmunoProtect, Monoclonal Development, Polyclonal Development, Antibody Protection, Peptide Production and Cryopreservation Services. Its antibody products include...
James Kuo M.D.
Chairman
Jennifer Bath Ph.D.
President
Lisa Helbling
Chief Financial Officer
Charles Wheelock
Chief Technology Officer
Kari Graber
Vice President
Address
880 - 580 HORNBY STREET
Vancouver, BC
V6C3B6
Canada